BCL6 and cancer: It has been reported that BCL6 (B-cell CLL/lymphoma 6) is an miR-127 target in cancer cells13, 23, 31 whose expression is upregulated during myogenic differentiation in C2C12 cells,32 suggesting that miR-127 might promote myogenic differentiation by targeting BCL6.